BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12758097)

  • 21. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
    Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
    Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study.
    Younis JS; Izhaki I; Ben-Ami M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):99-106. PubMed ID: 26304041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to ovarian stimulation.
    Diedrich K; Felberbaum R
    Hum Reprod; 1998 Jun; 13 Suppl 3():1-13; discussion 14-7. PubMed ID: 9755411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.
    Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W
    Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.
    Borm G; Mannaerts B
    Hum Reprod; 2000 Jul; 15(7):1490-8. PubMed ID: 10875855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders].
    Fauser BC; Laven JS; de Jong D; Macklon NS
    Ned Tijdschr Geneeskd; 2000 Feb; 144(8):370-4. PubMed ID: 10703589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro fertilisation. A review of drug therapy and clinical management.
    Jennings JC; Moreland K; Peterson CM
    Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antagonists in ovarian stimulation protocols.
    Dal Prato L; Borini A
    Reprod Biomed Online; 2005 Mar; 10(3):330-8. PubMed ID: 15820038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis.
    Oliveira JB; Mauri AL; Petersen CG; Martins AM; Cornicelli J; Cavanha M; Pontes A; Baruffi RL; Franco JG
    J Assist Reprod Genet; 2007; 24(2-3):67-75. PubMed ID: 17195098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
    Kol S
    Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870
    [No Abstract]   [Full Text] [Related]  

  • 36. A short review of ovarian stimulation in assisted reproductive techniques.
    Cohen J
    Reprod Biomed Online; 2003; 6(3):361-6. PubMed ID: 12735875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
    Samara N; Reis D; Danielli Miller N; Ghetler Y; Berkovitz A; Miller M; Gonen O; Shulman A; Wiser A
    Gynecol Endocrinol; 2015; 31(11):877-9. PubMed ID: 26416777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.